KYLYS is assigned exclusive worldwide rights by University of Geneva on an innovative technology based on hyaluronic acid (HA). HA, a naturally occurring biocompatible molecule found throughout the body that is a vital component of healthy joint and tissue...
Read More
We have presented our technology to a prestigious international meeting: the 44th Annual Meeting & Exposition of the Controlled Release Society in Boston, Massachusetts, United...
Read More
We have presented our technology to the most important world hyaluronan conference in Cleveland, Ohio, United States.
Read More
We have presented our experience “from researcher to entrepreneur” to a packed audience at the Centre Médical Universitaire on Tuesday, 2nd of May 2017, Geneva. This event was organised by UNITEC (www.unige.ch/unitec).
Read More
Every year since 2007 the University Hospital of Geneva (HUG), in partnership with the Geneva Faculty of Medicine, has organized Innovation Days where a multidisciplinary and international jury of experts analyzes more than 40 projects competing for the Innovation Day’s Academy Award. The innovations are often unconventional, groundbreaking, and always focused on patients’ health, safety, well-being and ultimately saving lives. Our...
Read More